Effective Management of Advanced Angiosarcoma by the Synergistic Combination of Propranolol and Vinblastine-based Metronomic Chemotherapy: A Bench to Bedside Study
Open Access
- 1 April 2016
- journal article
- research article
- Published by Elsevier in EBioMedicine
- Vol. 6, 87-95
Abstract
No abstract availableKeywords
Funding Information
- Children's Cancer Institute
- Balnaves Foundation
- Cancer Council New South Wales
- NHMRC Senior Research Fellowships (APP1058299)
- European Research Council (626794)
- Australian Research Council (CE140100036)
This publication has 32 references indexed in Scilit:
- Modeling human endothelial cell transformation in vascular neoplasiasDisease Models & Mechanisms, 2013
- Targeting of Beta Adrenergic Receptors Results in Therapeutic Efficacy against Models of Hemangioendothelioma and AngiosarcomaPLOS ONE, 2013
- Molecular Pathways: Beta-Adrenergic Signaling in CancerClinical Cancer Research, 2012
- Phase 2 Southwest Oncology Group‐directed intergroup trial (S0505) of sorafenib in advanced soft tissue sarcomasCancer, 2011
- Feasibility of metronomic oral cyclophosphamide plus prednisolone in elderly patients with inoperable or metastatic soft tissue sarcomaEuropean Journal of Cancer, 2011
- AngiosarcomaThe Lancet Oncology, 2010
- Role of β1‐adrenoceptor in increased lipolysis in cancer cachexiaCancer Science, 2010
- Envisioning the future of early anticancer drug developmentNature Reviews Cancer, 2010
- Phase II Study of Sorafenib in Patients With Metastatic or Recurrent SarcomasJournal of Clinical Oncology, 2009
- A 14-Year Retrospective Review of AngiosarcomaThe Cancer Journal, 2005